ОбзорГрафикНовостиTraderScreen

RAPT Therapeutics/  US75382E1091  /

IEX
15.11.2024  21:59:49 Изменение -0.18 Объем сделки Бид- Предложение- Максимум Минимум
1.10USD -14.06% 37,771
Оборот: 42,879.42		 -Величина цены спроса: - -Величина цены предложения: - 1.25 1.08
GlobeNewswire 08.08 RAPT Therapeutics Reports Second Quarter 2024 Financial Results
GlobeNewswire 09.05 INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against RAPT Therapeut...
GlobeNewswire 09.05 RAPT Therapeutics Reports First Quarter 2024 Financial Results
GlobeNewswire 09.04 RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with...
GlobeNewswire 12.03 RAPT ALERT: Bragar Eagel & Squire, P.C. is Investigating RAPT Therapeutics, Inc. on Behalf of RAPT S...
GlobeNewswire 07.03 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of RAPT Therapeutic...
GlobeNewswire 07.03 RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 05.03 RAPT Therapeutics Announces Multiple Late-Breaking Presentations at the Upcoming American Associatio...
GlobeNewswire 28.02 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of RAPT Therapeutic...
GlobeNewswire 21.02 RAPT Investigation Alert: Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claim...
GlobeNewswire 21.02 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of RAPT Therapeutic...
GlobeNewswire 20.02 Investigation of RAPT Therapeutics, Inc. (RAPT) Announced by Holzer & Holzer, LLC
GlobeNewswire 20.02 RAPT Therapeutics Announces Clinical Hold on Studies Evaluating Zelnecirnon
GlobeNewswire 13.02 RAPT Therapeutics Bolsters Leadership Team with the Appointment of Nipun Davar, Ph.D., as Senior Vic...
GlobeNewswire 31.01 RAPT Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Confere...
GlobeNewswire 02.01 RAPT Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire 27.11.2023 RAPT Therapeutics Announces Publication of Phase 1a/1b Clinical Trial of Zelnecirnon (RPT193) to Tre...
GlobeNewswire 13.11.2023 RAPT Therapeutics Reports Third Quarter 2023 Financial Results
GlobeNewswire 03.11.2023 RAPT Therapeutics Announces Positive Data, Including Objective Response Rates and Progression-Free S...
GlobeNewswire 01.11.2023 RAPT Therapeutics to Participate in Several Upcoming Investor Conferences in November
GlobeNewswire 18.10.2023 RAPT Therapeutics Announces Two FLX475 Presentations at the Society for Immunotherapy of Cancer (SIT...
GlobeNewswire 30.08.2023 RAPT Therapeutics to Participate in Several Upcoming Investor Conferences in September
GlobeNewswire 28.03.2022 RAPT Therapeutics Announces Biomarker Data from Phase 1b Trial of RPT193 Consistent with Disease Mod...
GlobeNewswire 10.03.2022 RAPT Therapeutics Reports Fourth Quarter and Year End 2021 Financial Results
GlobeNewswire 15.02.2022 Portage Biotech Announces New Appointments to its Management Team and Board of Directors